Since tumor classification based on gene expression profiles/signatures has shown more accuracy than classification based on single biomarkers, we hypothesized that an ELK4‐SP1/3 complex‐regulated gene signature could more precisely predict the prognosis of CRC patients. This evidence concerns the gene ELK4 and neoplasm.